Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risks and safety practices in hemapheresis procedures.

D W Huestis1

  • 1Department of Pathology, University of Arizona, College of Medicine, Tucson 85724.

Archives of Pathology & Laboratory Medicine
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dosage in neutrophil transfusions.

Vox sanguinis·2002
Same author

The life and death of Alexander Bogdanov, physician.

Journal of medical biography·1996
Same author

Adverse clinical effects of immune sorption with staphylococcal protein A columns.

Transfusion medicine reviews·1996
Same author

The neutrophil in transfusion medicine.

Transfusion·1994
Same author

Donors and dollars.

Transfusion·1994
Same author

Therapeutic cytoreduction in a 7-month-old baby with acute leukemia.

Journal of clinical apheresis·1992
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Hemapheresis in healthy donors carries risks similar to blood donation, plus risks from cell separators and component loss. For patients, hemapheresis requires careful physician consultation due to lower tolerance and more radical depletions.

Area of Science:

  • Medical Science
  • Hematology
  • Transfusion Medicine

Background:

  • Hemapheresis is used for blood component collection in donors and therapeutic depletions in patients.
  • Donors face standard blood donation risks plus risks associated with cell separators and component loss.
  • Patients have lower tolerance for hemapheresis and undergo more radical component depletions than donors.

Purpose of the Study:

  • To outline the distinct considerations and physician responsibilities for hemapheresis in donors versus patients.
  • To emphasize the critical role of physician oversight in ensuring donor safety and effective therapeutic outcomes.
  • To highlight the consultative and decision-making aspects of therapeutic hemapheresis for patient care.

Main Methods:

  • Review of hemapheresis procedures for blood component collection in donors.

Related Experiment Videos

  • Analysis of therapeutic hemapheresis applications in patients.
  • Discussion of physician roles in managing risks, efficacy, and patient consent for both procedures.

    • Main Results:

    • Donor hemapheresis requires managing risks of donation, cell separation, and component loss.
    • Patient hemapheresis involves greater risks due to reduced tolerance and radical depletions.
    • Physician's active consultative role is crucial for therapeutic hemapheresis, including risk assessment, consent, scheduling, and supervision.

    Conclusions:

    • Hemapheresis procedures demand distinct management strategies for donors and patients.
    • Physician vigilance is paramount in mitigating risks and optimizing outcomes in all hemapheresis procedures.
    • Therapeutic hemapheresis necessitates a collaborative approach between the responsible physician and the clinical team.